about
Novel Insights into the Roles of Rho Kinase in CancerMolecular classification of gastric cancer: Towards a pathway-driven targeted therapyMorphological Changes of Human Corneal Endothelial Cells after Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) Administration: A Prospective Open-Label Clinical Study.Effects of K-115 (Ripasudil), a novel ROCK inhibitor, on trabecular meshwork and Schlemm's canal endothelial cells.RhoA Signaling and Synaptic Damage Occur Within Hours in a Live Pig Model of CNS Injury, Retinal Detachment.Netarsudil Increases Outflow Facility in Human Eyes Through Multiple Mechanisms.Inhibition of Rho Kinase Induces Antioxidative Molecules and Suppresses Reactive Oxidative Species in Trabecular Meshwork Cells.Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions.Modulation of Microglial Activity by Rho-Kinase (ROCK) Inhibition as Therapeutic Strategy in Parkinson's Disease and Amyotrophic Lateral Sclerosis.Rho Kinases and Cardiac Remodeling.Role of the Rho GTPase/Rho kinase signaling pathway in pathogenesis and treatment of glaucoma: Bench to bedside research.Rho kinase inhibitors: a patent review (2014 - 2016).Epigenetics and Signaling Pathways in Glaucoma.Central Angiotensin-II Increases Blood Pressure and Sympathetic Outflow via Rho Kinase Activation in Conscious Rabbits.Application of Rho Kinase Inhibitors for the Treatment of Corneal Endothelial Diseases.Efficient Pathway for the Preparation of Aryl(isoquinoline)iodonium(III) Salts and Synthesis of Radiofluorinated Isoquinolines.Additive Intraocular Pressure-Lowering Effects of Ripasudil with Glaucoma Therapeutic Agents in Rabbits and MonkeysComparison of intraocular pressure-lowering effects of ripasudil hydrochloride hydrate for inflammatory and corticosteroid-induced ocular hypertension.Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis.Corneal Endothelial Cell Migration and Proliferation Enhanced by Rho Kinase (ROCK) Inhibitors in In Vitro and In Vivo Models.Research advances in kinase enzymes and inhibitors for cardiovascular disease treatment.Ripasudil hydrochloride hydrate: targeting Rho kinase in the treatment of glaucoma.Novel therapeutics in glaucoma management.Effects of ripasudil hydrochloride hydrate (K-115), a Rho-kinase inhibitor, on ocular blood flow and ciliary artery smooth muscle contraction in rabbits.Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma.Quantitative analysis of ripasudil hydrochloride hydrate and its impurities by reversed-phase high-performance liquid chromatography after precolumn derivatization: Identification of four impurities.Effects of Ripasudil Hydrochloride Hydrate Instillation on Pupil Dynamics.Role of inhibiting LIM-kinase2 in improving erectile function through suppression of corporal fibrosis in a rat model of cavernous nerve injury.A multiethnic genome-wide association study of primary open-angle glaucoma identifies novel risk loci.Use of Rho kinase Inhibitors in Ophthalmology: A Review of the Literature
P2860
Q26771368-9EFEAFF3-3D37-41D2-9688-93B1492A99D7Q26798420-3EC8722F-6B0B-4CE5-9FBE-87010C839224Q35772897-A76CEBF8-3653-4CB7-A63B-E939CAC743AEQ36499750-FCAA9394-0817-4EFD-B265-2DDFFD1007A3Q37152871-83F962F9-3216-4C7D-97EE-78DC8F3879AEQ37420927-C6E5EF78-769E-462C-8EB7-DFA93FD8E3D1Q38429920-21E4E449-7390-4A31-9608-FEE6D8D3D974Q38584194-2B93BBCB-A737-44B3-BCCB-4297CDF344D6Q38728605-890C8770-6BCB-49B0-9195-5BA62680BE4CQ38850635-BE6AB68C-EE59-4B3E-AA83-E36E3A5F5980Q38946178-35FE0EBA-1256-453B-B792-D6D48F8B0A72Q39065919-30970F83-BCE4-4D22-81C8-8AC142C80AE7Q39140153-EF6ABBF2-ABB3-41F7-8445-474B6F8340D1Q39348251-AF02705C-37D9-4039-8A7E-A670EACB6F60Q41023019-BE9EB7D0-BA61-4863-BE32-3A51463D6079Q41719499-02854D1C-D635-4A63-B931-59BA9E2C441AQ42127523-7CBB2C5E-4B80-4A93-886C-C515948F9D46Q42368944-DD3691DF-92A5-4687-8269-A2C7F6B40DC0Q45987365-1BDF1100-FDEB-46C6-BF9B-2894A4329D26Q46734950-46CA6E47-5075-4C70-A50E-00CADB2D116DQ47121794-FCCBF10F-B271-46FD-A1B3-FC9D225A2F36Q47822162-AE666F6D-7F8A-4195-B61B-179F0478275AQ50023818-B863B737-BACC-41AA-A46F-354AFC219242Q50921528-C585886D-6F51-4A7E-9E3D-D8D9FADA5F68Q50947105-78B584F9-6226-453C-BC79-2B8C153E925EQ51259572-43D02245-7C90-45B7-9161-BCD53ABB95C3Q51726357-7E4C3A7D-5DC9-47A9-9600-C7BB456891C8Q54982368-BE6AB10C-58D7-49C9-8BBD-88C828C5EDEDQ55157765-BD1D4AF8-84D2-4B16-BD71-3F292D8D5C98Q58597213-EB6ABB46-8DF3-4EA4-B85D-F2DC303BB415
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Ripasudil: first global approval.
@ast
Ripasudil: first global approval.
@en
Ripasudil: first global approval.
@nl
type
label
Ripasudil: first global approval.
@ast
Ripasudil: first global approval.
@en
Ripasudil: first global approval.
@nl
prefLabel
Ripasudil: first global approval.
@ast
Ripasudil: first global approval.
@en
Ripasudil: first global approval.
@nl
P2860
P1433
P1476
Ripasudil: first global approval.
@en
P2860
P2888
P304
P356
10.1007/S40265-014-0333-2
P577
2014-12-01T00:00:00Z
P6179
1032502680